Cargando…
Recent Progress in Shigella and Burkholderia pseudomallei Vaccines
Significant advancement has been made in the development of vaccines against bacterial pathogens. However, several roadblocks have been found during the evaluation of vaccines against intracellular bacterial pathogens. Therefore, new lessons could be learned from different vaccines developed against...
Autores principales: | Chapartegui-González, Itziar, Bowser, Sarah, Torres, Alfredo G., Khakhum, Nittaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621228/ https://www.ncbi.nlm.nih.gov/pubmed/34832508 http://dx.doi.org/10.3390/pathogens10111353 |
Ejemplares similares
-
P22-Based Nanovaccines against Enterohemorrhagic Escherichia coli
por: Huerta-Saquero, Alejandro, et al.
Publicado: (2023) -
Burkholderia pseudomallei BicA protein promotes pathogenicity in macrophages by regulating invasion, intracellular survival, and virulence
por: Stockton, Jacob L., et al.
Publicado: (2023) -
Development of Melioidosis Subunit Vaccines Using an Enzymatically Inactive Burkholderia pseudomallei AhpC
por: Schmidt, Lindsey K., et al.
Publicado: (2022) -
Cloning, expression, and characterization of a peptidoglycan hydrolase from the Burkholderia pseudomallei phage ST79
por: Khakhum, Nittaya, et al.
Publicado: (2016) -
Dual RNA-seq reveals a type 6 secretion system-dependent blockage of TNF-α signaling and BicA as a Burkholderia pseudomallei virulence factor important during gastrointestinal infection
por: Sanchez-Villamil, Javier I., et al.
Publicado: (2022)